NO20035670L - En ny G-proteinkoplet reseptor, GAVE 3 - Google Patents

En ny G-proteinkoplet reseptor, GAVE 3

Info

Publication number
NO20035670L
NO20035670L NO20035670A NO20035670A NO20035670L NO 20035670 L NO20035670 L NO 20035670L NO 20035670 A NO20035670 A NO 20035670A NO 20035670 A NO20035670 A NO 20035670A NO 20035670 L NO20035670 L NO 20035670L
Authority
NO
Norway
Prior art keywords
gave
protein
new
coupled receptor
receptor
Prior art date
Application number
NO20035670A
Other languages
English (en)
Other versions
NO20035670D0 (no
Inventor
Tai-He Xia
Donghui Ni
Haifeng Eishingdrelo
Ali Ardati
Anne Minnich
Ray Jupp
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of NO20035670D0 publication Critical patent/NO20035670D0/no
Publication of NO20035670L publication Critical patent/NO20035670L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
NO20035670A 2001-06-22 2003-12-18 En ny G-proteinkoplet reseptor, GAVE 3 NO20035670L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/886,041 US20030059869A1 (en) 2001-06-22 2001-06-22 Novel G protein-coupled receptor, GAVE3
PCT/US2002/019490 WO2003000846A2 (en) 2001-06-22 2002-06-21 A novel g protein-coupled receptor, gave 3

Publications (2)

Publication Number Publication Date
NO20035670D0 NO20035670D0 (no) 2003-12-18
NO20035670L true NO20035670L (no) 2004-02-19

Family

ID=25388250

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035670A NO20035670L (no) 2001-06-22 2003-12-18 En ny G-proteinkoplet reseptor, GAVE 3

Country Status (10)

Country Link
US (1) US20030059869A1 (no)
JP (1) JP2005500036A (no)
KR (1) KR20040022432A (no)
AR (1) AR036104A1 (no)
BR (1) BR0210937A (no)
CA (1) CA2451686A1 (no)
IL (1) IL159477A0 (no)
MX (1) MXPA03011843A (no)
NO (1) NO20035670L (no)
WO (1) WO2003000846A2 (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2077913B1 (de) * 2006-09-29 2013-01-02 Basf Se Verfahren zur regenerierung eines filterhilfsmittels

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU784543B2 (en) * 1999-11-16 2006-04-27 Pharmacia & Upjohn Company Novel G protein-coupled receptors

Also Published As

Publication number Publication date
US20030059869A1 (en) 2003-03-27
AR036104A1 (es) 2004-08-11
MXPA03011843A (es) 2004-03-26
BR0210937A (pt) 2006-10-24
KR20040022432A (ko) 2004-03-12
CA2451686A1 (en) 2003-01-03
JP2005500036A (ja) 2005-01-06
WO2003000846A3 (en) 2004-03-04
WO2003000846A2 (en) 2003-01-03
NO20035670D0 (no) 2003-12-18
IL159477A0 (en) 2004-06-01

Similar Documents

Publication Publication Date Title
ATE400558T1 (de) Metabotropische glutamatrezeptor-antagonisten
NO20043022L (no) 5,6-diaryl-pyrazin-2-amid-derivater som CB1-antagonister
AUPR833401A0 (en) G protein-coupled receptor antagonists
DE60224221D1 (de) Aminotetralinderivate, antagonisten von muscarinrezeptoren
DE60141896D1 (de) N,n'-diarylguanidine als il-8-rezeptor-antagonisten
DE60315471D1 (de) 2,5-disubstituierte 3-mercaptopentansaure
NO20035670L (no) En ny G-proteinkoplet reseptor, GAVE 3
NO20041776L (no) En ny G-proteinkoblet reseptor, GAVE10
NO20040252L (no) En ny G-proteinkoblet reseptor, GAVE8
AU2001247653A1 (en) 43238, a novel g protein-coupled receptor and uses therefor
ATE320254T1 (de) Crf receptor antagonisten
ATE470655T1 (de) Substituierte 1,5-diaminopentan-3-ol-verbindungen
IS7131A (is) Nýjar 2,4-díamínóþíasól afleiður
AU4992301A (en) Novel g protein-coupled receptors
GB0125704D0 (en) A novel g protein-coupled receptor gaves
AU2002341845A1 (en) 15625 receptor, a novel g-protein coupled receptor
AU2002311965A1 (en) A novel g protein-coupled receptor, gave1
AU2002367973A8 (en) Mid 241 receptor, a novel g-protein coupled receptor
AU5961201A (en) Novel g protein-coupled receptors
AU4551401A (en) Novel g protein-coupled receptors
ITNU20010001U1 (it) "erogatore sprint"
SE0003996D0 (sv) Receptorantagonister
NO20042386L (no) En nukleinsyre som koder for en G-proteinkoplet reseptor, og anvendelser derav
SE0101465D0 (sv) A bushing
IS7299A (is) 3,4-díhýdró-1H-ísókínólóín-2-ýl-afleiður

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application